Showing 101 - 110 of 1,228
The contribution of new technology to economic growth can only be realized when and if the new technology is widely diffused and used. Diffusion itself results from a series of individual decisions to begin using the new technology, decisions which are often the result of a comparison of the...
Persistent link: https://www.econbiz.de/10005580436
This paper explores the characteristics of 238 patents on 94 "inventions" contributed by major multinational innovators to the "Eco-Patent Commons", which provides royalty-free access to third parties to patented climate change related innovations. By comparing the pledged patents to other...
Persistent link: https://www.econbiz.de/10008927017
Persistent link: https://www.econbiz.de/10008927025
This paper discusses methods for the harmonization and combination of large-scale patent and trademark datasets with each other and other sources of data. Dictionary- and rule-based approaches to the consolidation of applicant names in patent data are presented and shown to have both benefits...
Persistent link: https://www.econbiz.de/10008614654
We review the econometric literature on measuring the returns to R&D. The theoretical frameworks that have been used are outlined, followed by an extensive discussion of measurement and econometric issues that arise when estimating the models. We then provide a series of tables summarizing the...
Persistent link: https://www.econbiz.de/10008624599
What do we know about the relationship between innovation and productivity among firms? The workhorse model of this relationship is presented and the implications of analysis using this model and the usually available data on product and process innovation are derived. The recent empirical...
Persistent link: https://www.econbiz.de/10009147975
Persistent link: https://www.econbiz.de/10008681070
We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between “primary” (active ingredient) and “secondary” patents (patents on modified compounds, formulations, dosages, particular medical uses etc.). There is prior evidence that secondary...
Persistent link: https://www.econbiz.de/10011189095
Persistent link: https://www.econbiz.de/10005571514
Persistent link: https://www.econbiz.de/10000769971